After several years of development and clinical trials we founded Elixion Medical in 2021 to make our SmartDrain available to healthcare providers worldwide. SmartDrain is our first contribution to the digital transformation of the healthcare sector – more are going to follow. We make postoperative care easier and safer.
Certif-ID is a skills ecosystem that supports Educators, Industry, and candidates to source, manage, and develop talent that meets industry standards. Built on the European ESCO (European Skills, Competences, Qualifications, and Occupations) framework we are harmonizing job profiles and matching skills to jobs. With an interconnected network of training and industry partners, we support individuals to learn the right skills, and enable industry to source and match competent professionals with their demands. With this in mind, the Certif-ID solution supports companies to both manage internal talent development and source talent from the market. Certif-ID is built on blockchain technology which we believe has tremendous potential to support the end to end labour market. In addition, we have built an intelligent matching engine that uses data to match and source candidates to jobs. With SkillPass we give candidates a digital window to the recruitment market where they can store video interviews, CVs, References, project work, and more. Our aim is to support companies to overcome their skills shortages, particularly in developing markets, and manage their internal talent pool. The following provides an overview of the areas where we as Certif-ID have been able to support our network of partners.
consalio helps management stay in control of the advisor's spending before the bill arrives and increases the impact of external partnerships. It is an advisory spend management solution company. An online inquiry form is available on their website.
Drop Friends is an app that accepts packages for your community and ties them to an office or hotel at the time of delivery. It is a platform for parcel shipments.
Fimo Health is building the leading ecosystem for patients suffering from fatigue in chronic diseases by combining data, science and technology. Our solution is already available for Long Covid, Multiple Sclerosis and ME/CFS (only CE-certified solution for Long Covid) and soon will follow a version for Oncology. The app is already reimbursed by several health insurances with more than 20 million members.
EINHUNDERT Energie GmbH distributes and supplies electricity to residential and commercial customers. It offers digital electricity meters, as well as a mobile application for monitoring electricity consumption. It also installs solar panels on roofs of urban rental properties and commercial real estate. The company was founded in 2017 and is based in Cologne, Germany.
Multiple vehicles (we call them ducks) can form a train for efficient transportation on longer distances within cities and industry areas. Ducktrain provides vehicle platforms and automation technology that will change urban and industrial logistics.
Emergence Therapeutics AG develops novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers. The company was incorporated in 2019 and is based in Duisburg, Germany.
Operaize GmbH, based in Cologne, Germany, specializes in developing an artificial intelligence platform known as Cognitive Operations, which is designed to enhance production planning for manufacturing clients. This cloud-based platform integrates seamlessly with existing planning landscapes through APIs or specialized SAP integration, addressing various planning challenges. Cognitive Operations efficiently collects and restructures planning and master data from current ERP and planning systems, allowing it to generate optimal production plans within seconds based on predefined conditions and objectives. Additionally, the platform supports clients in identifying potential faults, risks, and failures in their operations, enabling them to devise effective strategies to mitigate these issues and improve overall efficiency in the industrial value chain.
The company intends to use the funds to advance its arenavirus-based lead candidates towards clinical testing. They will develop the initial product candidates using its proprietary Fast Evolution platform, which will generate virus strains with optimized anti-tumoral properties. These candidates will be selected based on their ability to re-program the immune system to specifically and efficiently eliminate the malignant tumor tissue.
CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system.
CAP-Go enables the production of proteins “beyond antibodies”. Complex, glycosylated proteins represent a significant portion of the human proteome and are notoriously difficult to express in conventional cell lines such as CHO. The CAP-Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for the highly efficient production of a broad range of difficult to express recombinant proteins with authentic human post-translational modifications or on demand tailor-made glycosylation patterns.
Masterplan.com GmbH, based in Bochum, Germany, specializes in e-learning solutions focused on digital skills. Founded in 2017, the company develops structured courses that combine video lectures, quizzes, and knowledge reviews to facilitate digital education for employees. By collaborating with internationally recognized digital experts and utilizing an in-house film team, Masterplan creates practical and engaging content that supports companies in managing their digital transformation. The platform's gamified approach enhances the learning experience, making it an effective tool for organizations looking to equip their workforce with essential digital competencies.
aifora GmbH, founded in 2017 and based in Düsseldorf, Germany, develops a platform aimed at understanding and predicting consumer behavior, primarily for retail companies. The company’s software provides solutions that include price optimization and stock management, addressing aspects such as delivery splits, optimal order quantities, and inventory oversight across merchandise categories. aifora emphasizes the importance of the data-sharing economy by making data accessible and actionable for brands and retailers, enabling informed business decisions and enhancing consumer experiences. Utilizing deep learning algorithms, the platform offers targeted pricing, promotions, and merchandise flow strategies to influence customer behavior effectively. Additionally, aifora's intelligent automation reduces repetitive tasks, allowing merchandisers to concentrate on product innovation and improving customer experience.
Semalytix’s Pharos is an AI-based real world evidence generation tool that ingests data and breaks it down so you can receive specific information about the disease you’re investigating — zooming into specific target populations and studying nearly any variable you are interested in.
eevie is a pro-active eco-guide that enables people to live a more mindful and sustainable lifestyle. eevie helps us make small changes on a daily basis by nudging us with actionable information in the right moments and by provide immediate feedback on how conscious decisions affect our day-to-day carbon footprint, from commuting to work to sourcing local produce and reducing plastic waste. In order to support behaviour change, we have developed a system that uses machine learning to understand the daily routines of eevie users. This enables eevie to provide useful guidance and information in the relevant places and moments instead of generic out of place solutions. eevie, therefore, instantly helps us gain a greater awareness of our environment, and over time helps us adopt new habits to live a more eco-friendly lifestyle. We believe that our technology has the power to bring together a global community of people and empower them to change their ways, giving every individual the ability to contribute meaningfully in protecting our environment.
*Where customer service becomes customer loyalty* Discover Lupiter, the customer service platform that empowers agents and increases customer loyalty. Make every moment count, from first contact to peak lifetime value. Create value in every customer interaction through exceptional experiences. Achieve higher customer satisfaction, increased and lasting loyalty. Lupiter is developing a software platform for customer engagement. Our platform helps agents to save time and make their daily customer communications easier. We combine different channels like phone, email and chat in one easy to use cockpit. Lupiter stants for Value-driven customer service for outstanding business results.
talpasolutions a predictive SaaS analytics provider for the mining industry that helps companies optimize machine performance, reduce breakdowns, and improve safety by making data more understandable. talpasolutions makes it possible for operators and machine manufacturers in heavy industry to use machine data that would have otherwise been lost. talpasolutions concentrates on building visualization and analysis applications for the industrial internet. In the first step, large amounts of data from the machines are recorded. Comprehendable visualizations allow for different stakeholders to understand relationships based on sensor data and contextual data and to react to critical information, which would otherwise have been buried in the data transfer. In the second step the newest predictive models are applied to eliminate events such as errors and the breakdown of machines critical to the process. This increases not only the availability but also the workload of the machines. talpasolutions has built a network out of industry partners to develop solutions that stretch across various sectors and unify industry experience, data science, and workflow connectivity. Using predictive instructions our platform recognizes problems before they occur and supports users with workflow-based processes. Our applications make it possible to collect performance data from machines in order to recommend optimal fleet combinations for respective scenarios to customers. This leads to more operating hours, higher efficiency, and an improved lifetime value of the machines.
Social Impact Network is a fully decentralized ecosystem for impact investing. Social Impact Network empowers impact investors to earn high returns while effortlessly making a positive social impact.
Limbiq provides a browser-based Software-as-a-Service solution focused on supply chain management for B2B clients in various sectors, including industry, trade, and logistics. The company develops artificial intelligence-driven software that digitizes workflow and document management, enhancing operational efficiency. Limbiq's platform integrates all relevant partners, from suppliers to logistics service providers and end customers, facilitating seamless communication and collaboration. This comprehensive tool offers businesses transparency and real-time tracking of goods throughout the entire supply chain, enabling them to optimize their logistics and improve overall performance.
COMPEON is Germany’s leading financing portal for SMEs. Companies can obtain tailored offers from various financing partners for their planned projects by submitting a query free of charge at www.compeon.de. COMPEON works with more than 220 banks, leasing companies and special providers and handles financing enquiries with a total volume of €2.5 billion every year. In addition to credit, loans and leasing agreements, the firm brokers also factoring and alternative financing products – such as mezzanine capital, purchase and project financing or private debt. The fintech company has been on the market since 2013. In addition to its three founders and managing directors Kai Böringschulte, Dr Nico Peters and Dr Frank Wüller, COMPEON is owned by DvH Ventures, b-to-v and Tengelmann Ventures.
Ubirch GmbH, founded in 2014 and based in Cologne, Germany, specializes in Internet of Things (IoT) software security by leveraging blockchain technology. The company develops a cybersecurity solution that secures data at the source, enabling verification and trustworthiness across various industries, including production, insurance, energy, and logistics. Ubirch's technology employs a lightweight client capable of operating in constrained environments, facilitating the cryptographic signing of data from IoT sensors. This data is then verified against a public key and can be further processed through Ubirch's API for enhanced security and sustainability, particularly in sharing carbon footprint data for environmental, social, and governance (ESG) compliance. Ubirch's innovative approach aims to enhance data integrity while promoting sustainable practices within organizations.
CHRONEXT is a full-service platform for luxury watch trading. At CHRONEXT, you can buy watches, sell watches, and service watches in their in-house certified watchmaking atelier. In addition to brand new models, they offer pre-owned and vintage timepieces, all of which have undergone inspection for quality and authenticity in their watchmaking atelier.
The company intends to use the funds to advance its arenavirus-based lead candidates towards clinical testing. They will develop the initial product candidates using its proprietary Fast Evolution platform, which will generate virus strains with optimized anti-tumoral properties. These candidates will be selected based on their ability to re-program the immune system to specifically and efficiently eliminate the malignant tumor tissue.
Frontastic GmbH, founded in 2017 and based in Münster, Germany, specializes in providing a frontend as a service platform tailored for e-commerce. The company offers cloud-based software solutions that facilitate the integration of e-commerce systems with its platform, allowing users to create reusable web components and build customized sites. Frontastic's approach is centered on a "mobile first" philosophy, enabling online retailers, brands, marketplaces, and startups to enhance the digital customer experience with minimal IT effort. The platform serves as a comprehensive solution, providing tools for developers, online editors, and end customers, and has quickly gained recognition as a leading front-end solution in the API economy.
Social Impact Network is a fully decentralized ecosystem for impact investing. Social Impact Network empowers impact investors to earn high returns while effortlessly making a positive social impact.
Taxy.io GmbH, founded in 2018 and headquartered in Aachen, Germany, specializes in developing software for the automation of tax consulting and research. The company offers an AI-based platform that serves as a central information hub for digital tax intelligence, utilizing natural language processing and machine learning algorithms. This technology enables lawyers, tax consultants, auditors, and corporate finance professionals to efficiently analyze legal documents and case data, facilitating quick access to specific answers and solutions. By building digital assistants tailored for tax advisers, Taxy.io enhances the research and client advisory processes in the field of taxation.
EINHUNDERT Energie GmbH distributes and supplies electricity to residential and commercial customers. It offers digital electricity meters, as well as a mobile application for monitoring electricity consumption. It also installs solar panels on roofs of urban rental properties and commercial real estate. The company was founded in 2017 and is based in Cologne, Germany.
unu GmbH, founded in 2013 and based in Berlin, Germany, specializes in the design, development, and sale of electric scooters. The company launched its first product, the unu electric scooter, in the summer of 2014, aiming to provide a stylish, emission-free, and user-friendly urban mobility solution. unu GmbH offers various financing options and after-sales support services to enhance customer experience. Its products are available through both retail outlets and online channels, reflecting the company's commitment to connecting people with urban life.
Jamata Events UG is a company based in Lünen, Germany, founded in 2015, that operates a community platform for event organization and ticket sales. The platform enables event organizers to list their events, while users can search for and purchase tickets from various ticket providers. By aggregating event data from major ticket providers globally, Jamata Events facilitates a comprehensive search for music events, allowing bands, promoters, and event planners to effectively promote their activities.
Holocafé ist a franchiser company developing exclusive, shared-space VR experiences for location-based entertainment. Content aside, we have developed an entire one-stop platform solution to provide leisure operators with all tools they need: From ticketing and online payment over staff scheduling and accounting to store automization and content distribution. We are presently running three pilot stores in Germany with a fourth one scheduled to open this spring, in addition to a number of international licensees.
Banking One is able to predict which of retail banks customers are currently interested in financial products. Our product is used by sales managers in banks to filter out the most promising customers and distribute these customers to the sales agents. Resulting in higher earnings for the banks and happy customers since customers are contacted if there is a need and they will not be bothered for no reason.
Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop an innovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile.
unu GmbH, founded in 2013 and based in Berlin, Germany, specializes in the design, development, and sale of electric scooters. The company launched its first product, the unu electric scooter, in the summer of 2014, aiming to provide a stylish, emission-free, and user-friendly urban mobility solution. unu GmbH offers various financing options and after-sales support services to enhance customer experience. Its products are available through both retail outlets and online channels, reflecting the company's commitment to connecting people with urban life.
Personal MedSystems creates and sells products and services for mobile health and in particular Instant Cardiac Monitoring unparalleled in their innovation, ease-of-use and sophistication of design.
Personal MedSystems specializes in high level 12-lead ECG technology generated with reduced electrode systems. Their aim is to develop professional ECG systems that are implemented in personalized applications and used by private individuals. This requires creating exceptional ease of use.
Mapudo is a supplier-independent marketplace for for metals. Mapudo is bringing the metals supply industry online. They are the first company offering an independent online distribution channel for metals distributors and simplifying significantly metals procurement for buyers.
Rigontec GmbH is a biopharmaceutical company that develops RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The company develops ImOl100, a compound stimulating the immune receptor retinoic acid-inducible gene I, which recognizes viral RNA. Its ImOl100 is also a minimal mimic of naturally occurring 3pRNA, a motif typically occurring in viral RNAs. The company’s compounds avoid the pitfalls of cancer vaccines, checkpoint inhibitors, and therapeutics based on the identification of tumor antigens. Rigontec GmbH was founded in 2014 and is based in Planegg, Germany. As of October 26, 2017, Rigontec GmbH operates as a subsidiary of Merck & Co., Inc.
CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intends to extend the benefits of cryoenergy to the problem of diseased coronary arteries.
CHRONEXT is a full-service platform for luxury watch trading. At CHRONEXT, you can buy watches, sell watches, and service watches in their in-house certified watchmaking atelier. In addition to brand new models, they offer pre-owned and vintage timepieces, all of which have undergone inspection for quality and authenticity in their watchmaking atelier.
Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop an innovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile.
Bomedus is a medical device company that aims to make people with pain more mobile again. The Germany-based company was founded in 2011.
CHRONEXT is a full-service platform for luxury watch trading. At CHRONEXT, you can buy watches, sell watches, and service watches in their in-house certified watchmaking atelier. In addition to brand new models, they offer pre-owned and vintage timepieces, all of which have undergone inspection for quality and authenticity in their watchmaking atelier.
CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system.
CAP-Go enables the production of proteins “beyond antibodies”. Complex, glycosylated proteins represent a significant portion of the human proteome and are notoriously difficult to express in conventional cell lines such as CHO. The CAP-Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for the highly efficient production of a broad range of difficult to express recombinant proteins with authentic human post-translational modifications or on demand tailor-made glycosylation patterns.
PRECIRE Technologies specializes in speech analysis technology, focusing on the development of its proprietary PRECIRE® platform since 2012. This innovative system decodes written and spoken language to provide insights into the interactions of personality and behavior. It analyzes texts by breaking them down into numerous features, which are then compared to extensive, psychologically validated reference datasets. This process enables the software to generate detailed assessments of communication effects, emotions, personality traits, and linguistic competence for individuals or groups. By leveraging this technology, PRECIRE aims to enhance intelligent, personalized, and efficient interactions among employees, customers, applicants, and other conversational partners.
Rigontec GmbH is a biopharmaceutical company that develops RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The company develops ImOl100, a compound stimulating the immune receptor retinoic acid-inducible gene I, which recognizes viral RNA. Its ImOl100 is also a minimal mimic of naturally occurring 3pRNA, a motif typically occurring in viral RNAs. The company’s compounds avoid the pitfalls of cancer vaccines, checkpoint inhibitors, and therapeutics based on the identification of tumor antigens. Rigontec GmbH was founded in 2014 and is based in Planegg, Germany. As of October 26, 2017, Rigontec GmbH operates as a subsidiary of Merck & Co., Inc.
Mapudo is a supplier-independent marketplace for for metals. Mapudo is bringing the metals supply industry online. They are the first company offering an independent online distribution channel for metals distributors and simplifying significantly metals procurement for buyers.
Protagen is a precision medicine specialist that support drug development, facilitate treatment strategies and improve patient management. Protagen is at the forefront of immuno-profiling and the discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology. Protagen’s SeroTag® technology identifies biomarkers that address a number of challenges currently hindering the successful development and broader application of both cancer immunotherapies and novel treatments for autoimmune diseases. The company is a leader in patient stratification for autoimmune disease, having developed disease-specific NavigAID stratification panels that profile individual patient’s autoimmune condition and immune status. This precision medicine approach allows for the development and implementation of more targeted therapies for diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS) and others.
Vimecon GmbH develops and produces laser catheter for the treatment of heart diseases with a focus on Atrial Fibrillation. It also manufactures products for the medical technology and biotechnology; and offers microscopically small catheters, as well as micro materials handling techniques for exact measurement and dosage. In addition, Vimecon GmbH advises various customers from the scholar and industrial research and development. The company was founded in 2005 and is based in Herzogenrath, Germany.
CHRONEXT is a full-service platform for luxury watch trading. At CHRONEXT, you can buy watches, sell watches, and service watches in their in-house certified watchmaking atelier. In addition to brand new models, they offer pre-owned and vintage timepieces, all of which have undergone inspection for quality and authenticity in their watchmaking atelier.
Rigontec GmbH is a biopharmaceutical company that develops RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The company develops ImOl100, a compound stimulating the immune receptor retinoic acid-inducible gene I, which recognizes viral RNA. Its ImOl100 is also a minimal mimic of naturally occurring 3pRNA, a motif typically occurring in viral RNAs. The company’s compounds avoid the pitfalls of cancer vaccines, checkpoint inhibitors, and therapeutics based on the identification of tumor antigens. Rigontec GmbH was founded in 2014 and is based in Planegg, Germany. As of October 26, 2017, Rigontec GmbH operates as a subsidiary of Merck & Co., Inc.
AYOXXA Biosystems GmbH is a biotechnology company based in Cologne, Germany, with additional offices in Singapore and Boston, Massachusetts. Founded in 2010, AYOXXA specializes in life science tools, particularly through its proprietary technology platform for multiplexed protein analysis. The company has developed an innovative biochip technology that enables the simultaneous measurement of multiple protein markers associated with various health conditions, including cancer, allergies, cardiovascular diseases, and infectious diseases. AYOXXA's platform utilizes an in-situ encoded bead array, facilitating the identification and quantification of proteins and biomolecular analytes. This advanced approach to biomarker analysis positions AYOXXA at the forefront of diagnostic technology, allowing for comprehensive testing in a single assay.
CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intends to extend the benefits of cryoenergy to the problem of diseased coronary arteries.
evocatal develops and produces enzymes and fine chemicals for the chemical and pharmaceutical industries. We offer a catalog of enzymes (evozymes) as well as and tailor-made biocatalysts for specific industrial applications. Our biocatalysts are applied in various consumer goods industries, including the production and refinement of textiles, adhesives, detergents, nutrition and cosmetics. Our customers regard evocatal as a premium provider of high quality chiral building blocks (evochemicals): from a few grams to several tons. At evocatal we have also continued to focus on providing efficient biocatalytic processes as a service (evoservices). Do you need a biocatalyst for a very specific application? Contact us!
saperatec GmbH engages in the disposal and recycling of photovoltaic modules. The company engages in crushing the size of the material; developing separation liquids based on chemical mixtures that aid the separation of the composite; and washing, sorting, and drying of recovered materials. The company recycles used beverage cartons; packaging material made of aluminum and plastic; PV modules made of glass, semi-conductors, and plastic; li-ion batteries; and car glass. The company was founded in 2010 and is based in Bielefeld, Germany.
GreenPocket GmbH, based in Cologne, Germany, specializes in energy management software designed for utility companies. Founded in 2009, the company offers a range of innovative products that facilitate the interpretation and visualization of energy consumption data from smart meters. Their primary offerings include the GreenPocket Solution for household customers, a business customer portal for commercial users, and a smart home solution that enables efficient control of electrical appliances and monitoring devices. Additionally, GreenPocket provides tools such as online portals and applications that allow users to track their energy consumption and receive detailed summaries through newsletters and alerts. With experience in over 125 projects across 12 countries, GreenPocket aims to contribute to the energy transition and digitalization of the energy industry, positioning itself as a leading specialist in energy management and visualization software.
azeti is a Berlin-based high-tech company in the Internet of Things sector. Our IoT platform enables the simple and fast implementation of industrial IoT applications. We have been offering software "Made in Germany" for national and international customers since 2006. Our IoT solutions are in use in Europe, America and China. As specialists for digitization and IoT, our TÜV-certified IoT platform is already being used in a wide range of industries. Various research projects and long-term OEM partnerships in the industry underline our competence and expertise in solving the most demanding IoT projects. With our Open Source Edge Software and the brand new Application Enablement Platform we are going one step further and will make the Internet of Things possible for everyone.
CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system.
CAP-Go enables the production of proteins “beyond antibodies”. Complex, glycosylated proteins represent a significant portion of the human proteome and are notoriously difficult to express in conventional cell lines such as CHO. The CAP-Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for the highly efficient production of a broad range of difficult to express recombinant proteins with authentic human post-translational modifications or on demand tailor-made glycosylation patterns.
NonWoTecc GmbH was founded with the financial support of High-Tech Gründerfond (HTGF) and Rheinland Venture Capital Fond (RVC) in February of 2007. The goal was to develop a newly designed vascular prosthesis with improved biocompatible and bio-stable properties. NonWoTecc GmbH was one of only seven companies which received a commitment for financial support from HTGF in 2006.
Vimecon GmbH develops and produces laser catheter for the treatment of heart diseases with a focus on Atrial Fibrillation. It also manufactures products for the medical technology and biotechnology; and offers microscopically small catheters, as well as micro materials handling techniques for exact measurement and dosage. In addition, Vimecon GmbH advises various customers from the scholar and industrial research and development. The company was founded in 2005 and is based in Herzogenrath, Germany.
simfy GmbH operates as an online music platform. The company allows to share and store music online, as well as to listen instantly to specific tracks or albums via true on demand streaming. simfy GmbH was founded in 2006 and is based in Cologne, Germany.
Luxury Fashion Trade GmbH operates as an online retailer for handbags, evening gowns, jewelry and sun glasses. Luxury Fashion Trade GmbH was founded in 2008 and is headquartered in Frankfurt, Germany.
Protagen is a precision medicine specialist that support drug development, facilitate treatment strategies and improve patient management. Protagen is at the forefront of immuno-profiling and the discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology. Protagen’s SeroTag® technology identifies biomarkers that address a number of challenges currently hindering the successful development and broader application of both cancer immunotherapies and novel treatments for autoimmune diseases. The company is a leader in patient stratification for autoimmune disease, having developed disease-specific NavigAID stratification panels that profile individual patient’s autoimmune condition and immune status. This precision medicine approach allows for the development and implementation of more targeted therapies for diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS) and others.
simfy GmbH operates as an online music platform. The company allows to share and store music online, as well as to listen instantly to specific tracks or albums via true on demand streaming. simfy GmbH was founded in 2006 and is based in Cologne, Germany.
DIREVO provides customized solutions for various industries via the development and optimization of biocatalysts with its proprietary ultra-high-throughput screening platform. Serving the Feed & Food industries and chemical / biorefinery businesses, DIREVO products are developed either independently or in conjunction with global leaders such as Genencor (a division of Danisco A/S), AB Enzymes, Roal Ltd. and Nestlé. DIREVO Industrial Biotechnology GmbH is privately owned and located in Cologne, Germany. The shareholders include Wölbern EquityPartner GmbH (Hamburg), NRW Bank (Düsseldorf), TVM Capital (Munich), Danisco A/S (Copenhagen), a private equity firm affiliated with Sparkasse KölnBonn (Cologne), SandersMorrisHarris EnzymesLLC (New York), Mulligan BioCapital (Hamburg), and several private investors.
CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system.
CAP-Go enables the production of proteins “beyond antibodies”. Complex, glycosylated proteins represent a significant portion of the human proteome and are notoriously difficult to express in conventional cell lines such as CHO. The CAP-Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for the highly efficient production of a broad range of difficult to express recombinant proteins with authentic human post-translational modifications or on demand tailor-made glycosylation patterns.
DIREVO provides customized solutions for various industries via the development and optimization of biocatalysts with its proprietary ultra-high-throughput screening platform. Serving the Feed & Food industries and chemical / biorefinery businesses, DIREVO products are developed either independently or in conjunction with global leaders such as Genencor (a division of Danisco A/S), AB Enzymes, Roal Ltd. and Nestlé. DIREVO Industrial Biotechnology GmbH is privately owned and located in Cologne, Germany. The shareholders include Wölbern EquityPartner GmbH (Hamburg), NRW Bank (Düsseldorf), TVM Capital (Munich), Danisco A/S (Copenhagen), a private equity firm affiliated with Sparkasse KölnBonn (Cologne), SandersMorrisHarris EnzymesLLC (New York), Mulligan BioCapital (Hamburg), and several private investors.
Audimark GmbH provides marketing services for web radios. The company is based in Aachen, Germany.
CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system.
CAP-Go enables the production of proteins “beyond antibodies”. Complex, glycosylated proteins represent a significant portion of the human proteome and are notoriously difficult to express in conventional cell lines such as CHO. The CAP-Go expression platform comprises a portfolio of glyco-optimized human suspension cell lines for the highly efficient production of a broad range of difficult to express recombinant proteins with authentic human post-translational modifications or on demand tailor-made glycosylation patterns.
Innolume has invented a novel comb laser light engine for short-reach optical interconnects between and within computers. Economical wavelength-division multiplexing (WDM) is enabled by this class of low-cost, low-power Fabry-Perot lasers. WDM, familiar from telecom, provides an efficient alternative to multiple lasers and underutilized parallel fiber/waveguides, reducing short-reach system cost and power.
DIREVO provides customized solutions for various industries via the development and optimization of biocatalysts with its proprietary ultra-high-throughput screening platform. Serving the Feed & Food industries and chemical / biorefinery businesses, DIREVO products are developed either independently or in conjunction with global leaders such as Genencor (a division of Danisco A/S), AB Enzymes, Roal Ltd. and Nestlé. DIREVO Industrial Biotechnology GmbH is privately owned and located in Cologne, Germany. The shareholders include Wölbern EquityPartner GmbH (Hamburg), NRW Bank (Düsseldorf), TVM Capital (Munich), Danisco A/S (Copenhagen), a private equity firm affiliated with Sparkasse KölnBonn (Cologne), SandersMorrisHarris EnzymesLLC (New York), Mulligan BioCapital (Hamburg), and several private investors.
SCIENION AG is a life science company well positioned in the markets of ultra-low volume liquid handling systems and microarray technologies. They provide their customers with an integrated product portfolio facilitating and improving multiparallel bioanalytics, high throughput screening and high throughput production of microarrays in the genomics and proteomics fields – from early research to manufacturing.
Innolume has invented a novel comb laser light engine for short-reach optical interconnects between and within computers. Economical wavelength-division multiplexing (WDM) is enabled by this class of low-cost, low-power Fabry-Perot lasers. WDM, familiar from telecom, provides an efficient alternative to multiple lasers and underutilized parallel fiber/waveguides, reducing short-reach system cost and power.